AnalysisMode is a company headquartered in Switzerland.
AnalysisMode develops SimCell, an AI-driven cell culture simulation and digital twin platform plus bespoke AI services to help biopharma teams design experiments, optimize bioprocess parameters, and support scale-up and monitoring.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.